Jung, H.-M.; Ha, J.-H.; dela Cerna, M.V.C.; Burlison, J.A.; Choi, J.; Kim, B.-R.; Bang, J.K.; Ryu, K.-S.; Lee, D.
An Innovative Inhibitor with a New Chemical Moiety Aimed at Biliverdin IXβ Reductase for Thrombocytopenia and Resilient against Cellular Degradation. Pharmaceutics 2024, 16, 1148.
https://doi.org/10.3390/pharmaceutics16091148
AMA Style
Jung H-M, Ha J-H, dela Cerna MVC, Burlison JA, Choi J, Kim B-R, Bang JK, Ryu K-S, Lee D.
An Innovative Inhibitor with a New Chemical Moiety Aimed at Biliverdin IXβ Reductase for Thrombocytopenia and Resilient against Cellular Degradation. Pharmaceutics. 2024; 16(9):1148.
https://doi.org/10.3390/pharmaceutics16091148
Chicago/Turabian Style
Jung, Hoe-Myung, Jung-Hye Ha, Mark Vincent C. dela Cerna, Joseph A. Burlison, Joonhyeok Choi, Bo-Ram Kim, Jeong Kyu Bang, Kyoung-Seok Ryu, and Donghan Lee.
2024. "An Innovative Inhibitor with a New Chemical Moiety Aimed at Biliverdin IXβ Reductase for Thrombocytopenia and Resilient against Cellular Degradation" Pharmaceutics 16, no. 9: 1148.
https://doi.org/10.3390/pharmaceutics16091148
APA Style
Jung, H.-M., Ha, J.-H., dela Cerna, M. V. C., Burlison, J. A., Choi, J., Kim, B.-R., Bang, J. K., Ryu, K.-S., & Lee, D.
(2024). An Innovative Inhibitor with a New Chemical Moiety Aimed at Biliverdin IXβ Reductase for Thrombocytopenia and Resilient against Cellular Degradation. Pharmaceutics, 16(9), 1148.
https://doi.org/10.3390/pharmaceutics16091148